TD Private Client Wealth’s Tandem Diabetes Care TNDM Stock Holding History

TD Private Client Wealth’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$905	Hold	60	–	–	﹤0.01%	1487
2026 Q1	$1.15K	Hold	60	–	–	﹤0.01%	1362
2025 Q4	$1.32K	Buy	+60	New	+$1.08K	﹤0.01%	1327
2025 Q3	–	Sell	-36	Closed	-$671	–	1567
2025 Q2	$671	Buy	+36	New	+$713	﹤0.01%	1328
2022 Q1	–	Sell	-5	Closed	-$753	–	1328
2021 Q4	$753	Sell	5 -61	-92%	-$8.23K	﹤0.01%	1087
2021 Q3	$7.88K	Hold	66	–	–	﹤0.01%	929
2021 Q2	$6.43K	Buy	+66	New	+$5.88K	﹤0.01%	939

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

TD Private Client Wealth's TNDM Position: Q2 2026 in Review

TD Private Client Wealth held its Tandem Diabetes Care (TNDM) position steady in Q2 2026 at 60 shares worth $905. The position accounts for ﹤0.01% of the portfolio, ranked #1487.

TD Private Client Wealth first reported a position in TNDM in Q2 2021 and has held it in 7 quarters since. The position peaked at $7.88K in Q3 2021. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

TD Private Client Wealth held 60 shares of Tandem Diabetes Care worth $905 as of Q2 2026.
TD Private Client Wealth left its Tandem Diabetes Care share count unchanged in Q2 2026.
Tandem Diabetes Care made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #1487 holding.
TD Private Client Wealth first reported a position in Tandem Diabetes Care in Q2 2021 and has held it in 7 quarters since.
TD Private Client Wealth's Tandem Diabetes Care position peaked at $7.88K in Q3 2021.
273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.